Production of plant Sesquiterpenes in Saccharomyces cerevisiae:: Effect of ERG9 repression on sesquiterpene biosynthesis

被引:189
作者
Asadollahi, Mohammad A. [1 ]
Maury, Jerome [1 ]
Moller, Kasper [1 ]
Nielsen, Kristian Fog [1 ]
Schalk, Michel [2 ]
Clark, Anthony [2 ]
Nielsen, Jens [1 ]
机构
[1] Tech Univ Denmark, Ctr Microbial Biotechnol, BioCentrum DTU, DK-2800 Lyngby, Denmark
[2] Firmenich Co, Corp R&D Div, Geneva, Switzerland
关键词
sesquiterpenes; isoprenoids; mevalonate pathway; Saccharomyces cerevisiae; two-phase fermentation; farnesol;
D O I
10.1002/bit.21581
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The yeast Saccharomyces cerevisiae was chosen as a microbial host for heterologous biosynthesis of three different plant sesquiterpenes, namely valencene, cubebol, and patchoulol. The volatility and low solubility of the sesquiterpenes were major practical problems for quantification of the excreted sesquiterpenes. In situ separation of sesquiterpenes in a two-phase fermentation using dodecane as the secondary phase was therefore performed in order to enable quantitative evaluation of different strains. In order to enhance the availability of the precursor for synthesis of sesquiterpenes, farnesyl diphosphate (FPP), the ERG9 gene which is responsible for conversion of FPP to squalene was downregulated by replacing the native ERG9 promoter with the regulatable MET3 promoter combined with addition of 2 mM methionine to the medium. This strategy led to a reduced ergosterol content of the cells and accumulation of FPP derived compounds like target sesquiterpenes and farnesol. Adjustment of the methionine level during fermentations prevented relieving MET3 promoter repression and resulted in further improved sesquiterpene production. Thus, the final titer of patchoulol and farnesol in the ERG9 downregulated strain reached 16.9 and 20.2 mg/L, respectively. The results obtained in this study revealed the great potential of yeast as a cell factory for production of sesquiterpenes.
引用
收藏
页码:666 / 677
页数:12
相关论文
共 37 条
  • [21] Engineering a mevalonate pathway in Escherichia coli for production of terpenoids
    Martin, VJJ
    Pitera, DJ
    Withers, ST
    Newman, JD
    Keasling, JD
    [J]. NATURE BIOTECHNOLOGY, 2003, 21 (07) : 796 - 802
  • [22] The in vivo synthesis of plant sesquiterpenes by Escherichia coli
    Martin, VJJ
    Yoshikuni, Y
    Keasling, JD
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2001, 75 (05) : 497 - 503
  • [23] Microbial isoprenoid production: An example of green chemistry through metabolic engineering
    Maury, J
    Asadollahi, MA
    Moller, K
    Clark, A
    Nielsen, J
    [J]. BIOTECHNOLOGY FOR THE FUTURE, 2005, 100 : 19 - 51
  • [24] TERPENOID METABOLISM
    MCGARVEY, DJ
    CROTEAU, R
    [J]. PLANT CELL, 1995, 7 (07) : 1015 - 1026
  • [25] Miura Y, 1998, BIOTECHNOL BIOENG, V58, P306, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<306::AID-BIT29>3.0.CO
  • [26] 2-8
  • [27] Miura Y, 1998, APPL ENVIRON MICROB, V64, P1226
  • [28] 4 MAJOR TRANSCRIPTIONAL RESPONSES IN THE METHIONINE THREONINE BIOSYNTHETIC-PATHWAY OF SACCHAROMYCES-CEREVISIAE
    MOUNTAIN, HA
    BYSTROM, AS
    LARSEN, JT
    KORCH, C
    [J]. YEAST, 1991, 7 (08) : 781 - 803
  • [29] High-level production of amorpha-4,11-diene in a two-phase partitioning bioreactor of metabolically engineered Escherichia coli
    Newman, Jack D.
    Marshall, Jessica
    Chang, Michelle
    Nowroozi, Farnaz
    Paradise, Eric
    Pitera, Douglas
    Newman, Karyn L.
    Keasling, Jay D.
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2006, 95 (04) : 684 - 691
  • [30] Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli
    Pitera, Douglas J.
    Paddon, Chris J.
    Newman, Jack D.
    Keasling, Jay D.
    [J]. METABOLIC ENGINEERING, 2007, 9 (02) : 193 - 207